Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to provide follow-up histology tissue ...

Asian American women with breast cancer had higher survival rates than white women, though outcomes differed across ethnic ...

Cancer survival rates are consistently lower for patients living in the most deprived areas of the country, with some nearly ...

Breast cancer remains the most common cancer among women globally, with cases expected to surge by 2050. Researchers analyzed ...

Older age, White race, men, and Crohn disease were among the patient-specific factors associated with a greater risk for any skin cancer. The retrospective cohort study compared patients with ...

PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...

How Merck keeps the price of its blockbuster cancer drug sky-high, shutting out patients and straining health care systems ...

Absolute Difference in the Cema-Cel Arm Over the Observation Arm Exceeded Clinically Meaningful Benchmark Based on Literature ...

How Merck keeps the price of its lifesaving cancer drug, Keytruda, sky-high, locking out patients and squeezing health care ...

Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate ...

Beware of potential pitfalls today, as your focus may waver leading to small mistakes. Steer clear of heated discussions or ...

Almost 100% of patients with recurrent/metastatic endometrial cancer benefited from an investigational bispecific antibody ...